πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 27 of 78

  1. US 9950986

    Oils having antibacterial activity

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9951311

    Agents and methods to elicit anti-tumor immune response

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9951353

    Engineering neural stem cells using homologous recombination

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9944951

    Chromosome 3p21.3 genes are tumor suppressors

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9944927

    Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9944918

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9937191

    Inhibition of HIV infection through chemoprophylaxis

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9937196

    Genomic sequence of avian paramyxovirus type 2 and uses thereof

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9937217

    Method of inhibiting ABCG2 and related treatments

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9938526

    Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9932391

    Proteins with repetitive bacterial-IG-like (Big) domains present in Leptospira species

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9932372

    Designer peptide-based PCV2 vaccine

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9931377

    Cell expressing complexes of IL-15 and IL-15Ralpha

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9932406

    Human monoclonal antibodies specific for glypican-3 and use thereof

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9931393

    Immunogenic JC polyomavirus compositions and methods of use

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9925254

    Synthetic antigen constructs against Campylobacter jejuni

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9920296

    Paenibacillus alvei strain TS-15 and its use in controlling pathogenic organisms on crops

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9919058

    Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9919040

    Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9914773

    Anti-human folate receptor beta antibodies and methods of use

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9913892

    Materials and methods for respiratory disease control in canines

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9908841

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9902734

    Nicotinic acetylcholine receptor agonists

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9896484

    Influenza virus recombinant proteins

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9896509

    Use of antagonists of the interaction between HIV GP120 and Ξ±4Ξ²7 integrin

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9896511

    Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9890369

    Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9889115

    Fitness assay and associated methods

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9884104

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9884100

    Lutzomyia longipalpis polypeptides and methods of use

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9879231

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9879065

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9878972

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9873702

    Heterocyclic compounds as biogenic amine transport modulators

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9873893

    Methods and compositions for treating genetically linked diseases of the eye

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9868943

    Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vBβ€”SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9868769

    Mutated Salmonella enteriaca

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9867830

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9868774

    Anti-CD22 chimeric antigen receptors

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9868954

    Reduction of TGFΞ² signaling in myeloid cells in the treatment of cancer

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9861681

    Therapeutic compositions for neutralizing type I interferons, and methods of use

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9856313

    Epitope of RSV fusion protein and antibody recognizing the same

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9856453

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9855330

    Granulysin in immunotherapy

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9855312

    GHRH agonists for the treatment of ischemic disorders

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9855298

    Methods of conditioning patients for T cell therapy

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9856204

    Methods for inhibiting muscle atrophy

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.